News
A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...
The primary outcome assessed was a diagnosis of erectile dysfunction or the initiation of phosphodiesterase type 5 (PDE-5) inhibitor therapy, which is commonly used to treat ED. The study yielded the ...
Sex experts and medical doctors weigh in on the different types of erectile dysfunction, how to identify them, and solutions for erectile dysfunction.
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.
LGBTQ dating app Grindr is introducing Woodwork, a telehealth service that offers access to erectile dysfunction meds.
Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide—a drug known as Zepbound—on weight ...
Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.
Erectile dysfunction affects over 40% of men over 40, yet our understanding of the condition remains limited. Research on this issue has mostly relied on real organs, making it difficult to study ...
What to know about reports that some men on weight loss drugs are experiencing erectile dysfunction (ED).
Eli Lilly on Thursday unveiled a new $3 billion manufacturing investment, a move that will help the pharma shore up the production of its blockbuster obesity and diabetes injection tirzepatide as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results